Editorial: Regulatory T cells in graft versus host disease

被引：1
作者：
Rodriguez-Gil, Alfonso [1 ]
Perez-Simon, Jose A. [1 ,2 ]
Ritz, Jerome [3 ]
Lacerda, Joao F. [4 ,5 ]
Soares, Maria VD. [5 ]
机构：
[1] Univ Seville, Ctr Super Invest Cient, Inst Biomed Sevilla, IBIS CSIC, Seville, Spain
[2] Hosp Univ Virgen Rocio, Dept Hematol, Seville, Spain
[3] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[4] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Serv Hematol & Transplantacao Medula, Lisbon, Portugal
[5] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal
来源：
FRONTIERS IN IMMUNOLOGY | 2023年 / 13卷
基金：
欧盟地平线“2020”;
关键词：
regulatory T cells; graft-versus-host disease; recipient Tregs; hypomethylating agents; IL2;
D O I：
10.3389/fimmu.2022.1085220
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
[31]   Mesenchymal stromal cell supported umbilical cord blood ex vivo expansion enhances regulatory T cells and reduces graft versus host disease [J].
Fan, Xiubo ;
Gay, Florence Pik Hoon ;
Ong, Shin-Yeu ;
Ang, Justina May Lynn ;
Chu, Pat Pak Yan ;
Bari, Sudipto ;
Lim, Tony Kiat Hon ;
Hwang, William Ying Khee .
CYTOTHERAPY, 2013, 15 (05) :610-619
[32]   Mesenchymal stem cells for graft-versus-host disease:: Close encounters with T cells [J].
Dazzi, Francesco ;
Marelli-Berg, Federica M. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (06) :1479-1482
[33]   Depletion of host reactive T cells by photodynamic cell purging and prevention of graft versus host disease [J].
Goggins, TF ;
Chao, N .
LEUKEMIA & LYMPHOMA, 2003, 44 (11) :1871-1879
[34]   Vitamin D-modulated dendritic cells delay lethal graft-versus-host disease through induction of regulatory T cells [J].
Vanherwegen, An-Sofie ;
Cook, Dana Paulina ;
Ferreira, Gabriela Bomfim ;
Gysemans, Conny ;
Mathieu, Chantal .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 188 :103-110
[35]   Advances in the treatment of graft-versus-host disease with immunomodulatory cells [J].
Yu, Qianqian ;
Wang, Han ;
Zhang, Lingling ;
Wei, Wei .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 92
[36]   Graft-versus-host disease reduces regulatory T-cell migration into the tumour tissue [J].
Duerr, Christoph ;
Follo, Marie ;
Idzko, Marco ;
Reichardt, Wilfried ;
Zeiser, Robert .
IMMUNOLOGY, 2012, 137 (01) :80-88
[37]   Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease [J].
Karakhanova, S ;
Munder, M ;
Sehneider, M ;
Bonyhadi, M ;
Ho, AD ;
Goerner, M .
JOURNAL OF IMMUNOTHERAPY, 2006, 29 (03) :336-349
[38]   T cells, graft-versus-host disease and graft-versus-leukemia: Innovative approaches for blood and marrow transplantation [J].
Champlin, R ;
Giralt, S ;
Gajewski, J .
ACTA HAEMATOLOGICA, 1996, 95 (3-4) :157-163
[39]   Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells [J].
Fukui, Junichi ;
Inaba, Muneo ;
Ueda, Yusuke ;
Miyake, Takashi ;
Hosaka, Naoki ;
Kwon, A-Hon ;
Sakaguchi, Yutaku ;
Tsuda, Masanobu ;
Omae, Mariko ;
Kamiyama, Yasuo ;
Ikehara, Susumu .
STEM CELLS, 2007, 25 (06) :1595-1601
[40]   T cell metabolism in graft-versus-host disease [J].
Zou, Yujing ;
Chen, Benny J. .
BLOOD SCIENCE, 2020, 2 (01) :16-21
12345